(VIANEWS) - Nova Measuring Instruments Ltd. (NVMI), Vertex Pharmaceuticals (VRTX), Coca-Cola (KO) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Nova Measuring Instruments Ltd. (NVMI)
34.3% sales growth and 24.74% return on equity
Nova Ltd.
Nova Measuring Instruments Ltd.'s sales growth this year is expected to be 31.6% and 7.1% for next year.
Year-on-year quarterly revenue growth grew by 59.2%, now sitting on 465.94M for the twelve trailing months.
Volume
Today's last reported volume for Nova Measuring Instruments Ltd. is 87782 which is 36.73% below its average volume of 138761.
Nova Measuring Instruments Ltd.'s sales growth is a negative 0% for the ongoing quarter and 34.3% for the next. The company's growth estimates for the ongoing quarter and the next is 32.2% and negative -0.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 24.74%.
Volatility
Nova Measuring Instruments Ltd.'s last day, last week, and last month's current intraday variation average was 1.06%, 1.65%, and 2.20%, respectively.
Nova Measuring Instruments Ltd.'s highest amplitude of average volatility was 3.20% (day), 2.94% (last week), and 3.76% (last month), respectively.
Nova Measuring Instruments Ltd.'s Stock Yearly Top and Bottom Value
Nova Measuring Instruments Ltd.'s stock is valued at $105.35 at 16:22 EST, way under its 52-week high of $149.15 and way higher than its 52-week low of $81.63.
Nova Measuring Instruments Ltd.'s Moving Average
Nova Measuring Instruments Ltd.'s value is above its 50-day moving average of $97.55 and under its 200-day moving average of $111.31.2. Vertex Pharmaceuticals (VRTX)
16.3% sales growth and 24.93% return on equity
Vertex Pharmaceuticals Incorporated is involved in the development and marketing of therapies to treat cystic fibrosis.
Vertex Pharmaceuticals's sales growth this year is expected to be 13.2% and 7.8% for next year.
Year-on-year quarterly revenue growth grew by 27.3%, now sitting on 7.57B for the twelve trailing months.
Volume
Today's last reported volume for Vertex Pharmaceuticals is 1130360 which is 33.3% below its average volume of 1694720.
Vertex Pharmaceuticals's sales growth is a negative 0% for the current quarter and 16.3% for the next. The company's growth estimates for the present quarter and the next is 13.2% and 0.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 24.93%.
Volatility
Vertex Pharmaceuticals's last day, last week, and last month's current intraday variation average was 0.15%, 1.12%, and 1.07%, respectively.
Vertex Pharmaceuticals's highest amplitude of average volatility was 2.45% (day), 2.71% (last week), and 2.64% (last month), respectively.
Vertex Pharmaceuticals's Stock Yearly Top and Bottom Value
Vertex Pharmaceuticals's stock is valued at $273.64 at 16:22 EST, below its 52-week high of $296.84 and way higher than its 52-week low of $176.36.
Vertex Pharmaceuticals's Moving Average
Vertex Pharmaceuticals's worth is under its 50-day moving average of $275.65 and way above its 200-day moving average of $240.36.3. Coca-Cola (KO)
10.5% sales growth and 42.06% return on equity
Coca-Cola Company is a global beverage manufacturer, marketer, and seller of non-alcoholic beverages.
Coca-Cola's sales growth this year is expected to be 8.5% and 5.3% for next year.
Year-on-year quarterly revenue growth grew by 16.3%, now sitting on 40.13B for the twelve trailing months.
Volume
Today's last reported volume for Coca-Cola is 9865830 which is 43.82% below its average volume of 17561600.
News about Coca-Cola(KO) today
- According to today's article on VentureBeat, "In practice, Coca-Cola used this effect in their "Share a Coke with..." campaign to drive an 870% increase in traffic to their Facebook page. "
Coca-Cola's sales growth for the next quarter is 10.5%. The company's growth estimates for the present quarter and the next is a negative 1.5% and 1.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 42.06%.
Volatility
Coca-Cola's last day, last week, and last month's current intraday variation average was 0.17%, 0.95%, and 0.86%, respectively.
Coca-Cola's highest amplitude of average volatility was 1.01% (day), 1.82% (last week), and 1.68% (last month), respectively.
Coca-Cola's Stock Yearly Top and Bottom Value
Coca-Cola's stock is valued at $64.54 at 16:22 EST, below its 52-week high of $67.20 and way higher than its 52-week low of $52.28.
Coca-Cola's Moving Average
Coca-Cola's value is higher than its 50-day moving average of $63.25 and higher than its 200-day moving average of $59.60.4. Arrow Electronics (ARW)
9.5% sales growth and 21.17% return on equity
Arrow Electronics, Inc. offers products, services, solutions, and support to commercial and industrial users of electronic parts and enterprise computing solutions throughout the Americas, Europe, Middle East, Africa, Asia Pacific, and Asia.
Arrow Electronics's sales growth this year is expected to be 8.9% and a negative 1.2% for next year.
Year-on-year quarterly revenue growth grew by 6.6%, now sitting on 34.48B for the twelve trailing months.
Volume
Today's last reported volume for Arrow Electronics is 263480 which is 57.96% below its average volume of 626883.
Arrow Electronics's sales growth for the next quarter is 9.5%. The company's growth estimates for the current quarter and the next is 65% and 31.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 21.17%.
Volatility
Arrow Electronics's last day, last week, and last month's current intraday variation average was 1.64%, 1.62%, and 1.39%, respectively.
Arrow Electronics's highest amplitude of average volatility was 2.34% (day), 2.41% (last week), and 2.66% (last month), respectively.
Arrow Electronics's Stock Yearly Top and Bottom Value
Arrow Electronics's stock is valued at $120.47 at 16:22 EST, way below its 52-week high of $137.95 and way higher than its 52-week low of $105.34.
Arrow Electronics's Moving Average
Arrow Electronics's worth is above its 50-day moving average of $116.43 and under its 200-day moving average of $121.05.5. Choice Hotels International (CHH)
8.8% sales growth and 200.08% return on equity
Choice Hotels International, Inc., along with its subsidiaries, acts as an international hotel franchisor.
Choice Hotels International's sales growth this year is expected to be 13.2% and 5.1% for next year.
Year-on-year quarterly revenue growth grew by 40.9%, now sitting on 1.14B for the twelve trailing months.
Volume
Today's last reported volume for Choice Hotels International is 187918 which is 36.02% below its average volume of 293722.
Choice Hotels International's sales growth for the next quarter is 8.8%. The company's growth estimates for the ongoing quarter and the next is 18% and 4.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 200.08%.
Volatility
Choice Hotels International's last day, last week, and last month's current intraday variation average was 0.30%, 1.53%, and 1.35%, respectively.
Choice Hotels International's highest amplitude of average volatility was 1.54% (day), 2.36% (last week), and 2.84% (last month), respectively.
Choice Hotels International's Stock Yearly Top and Bottom Value
Choice Hotels International's stock is valued at $117.19 at 16:22 EST, way below its 52-week high of $157.46 and above its 52-week low of $108.70.
Choice Hotels International's Moving Average
Choice Hotels International's worth is below its 50-day moving average of $120.17 and way under its 200-day moving average of $137.39.6. Zoetis (ZTS)
8% sales growth and 47.76% return on equity
Zoetis Inc. develops, produces, markets, and sells diagnostic and animal medicine products, vaccines and other health products within the United States as well as internationally.
Zoetis's sales growth this year is anticipated to be 15.1% and 8.3% for next year.
Year-on-year quarterly revenue growth grew by 11.4%, now sitting on 7.62B for the twelve trailing months.
Volume
Today's last reported volume for Zoetis is 997811 which is 51.33% below its average volume of 2050390.
Zoetis's sales growth is a negative 0% for the ongoing quarter and 8% for the next. The company's growth estimates for the present quarter and the next is 0.9% and 11%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 47.76%.
Volatility
Zoetis's last day, last week, and last month's current intraday variation average was 0.15%, 1.68%, and 1.64%, respectively.
Zoetis's highest amplitude of average volatility was 1.66% (day), 2.85% (last week), and 2.38% (last month), respectively.
Zoetis's Stock Yearly Top and Bottom Value
Zoetis's stock is valued at $179.83 at 16:22 EST, way below its 52-week high of $231.91 and way above its 52-week low of $141.41.